These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Hypersulfated low molecular weight heparin with reduced affinity for antithrombin acts as an anticoagulant by inhibiting intrinsic tenase and prothrombinase. Anderson JA; Fredenburgh JC; Stafford AR; Guo YS; Hirsh J; Ghazarossian V; Weitz JI J Biol Chem; 2001 Mar; 276(13):9755-61. PubMed ID: 11134031 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms for inhibition of the generation of thrombin activity by sulfated polysaccharides. Ofosu FA; Modi GJ; Hirsh J; Buchanan MR; Blajchman MA Ann N Y Acad Sci; 1986; 485():41-55. PubMed ID: 2436525 [TBL] [Abstract][Full Text] [Related]
9. Model for the factor VIIIa-dependent decay of the intrinsic factor Xase. Role of subunit dissociation and factor IXa-catalyzed proteolysis. Fay PJ; Beattie TL; Regan LM; O'Brien LM; Kaufman RJ J Biol Chem; 1996 Mar; 271(11):6027-32. PubMed ID: 8626386 [TBL] [Abstract][Full Text] [Related]
10. Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex. Sheehan JP; Lan HC Blood; 1998 Sep; 92(5):1617-25. PubMed ID: 9716589 [TBL] [Abstract][Full Text] [Related]
11. The heparin-binding exosite is critical to allosteric activation of factor IXa in the intrinsic tenase complex: the role of arginine 165 and factor X. Misenheimer TM; Buyue Y; Sheehan JP Biochemistry; 2007 Jul; 46(26):7886-95. PubMed ID: 17563121 [TBL] [Abstract][Full Text] [Related]
12. Serpin-independent anticoagulant activity of a fucosylated chondroitin sulfate. Glauser BF; Pereira MS; Monteiro RQ; Mourão PA Thromb Haemost; 2008 Sep; 100(3):420-8. PubMed ID: 18766257 [TBL] [Abstract][Full Text] [Related]
13. Phosphorothioate oligonucleotides inhibit the intrinsic tenase complex by an allosteric mechanism. Sheehan JP; Phan TM Biochemistry; 2001 Apr; 40(16):4980-9. PubMed ID: 11305914 [TBL] [Abstract][Full Text] [Related]
14. Down-regulation of factor IXa in the factor Xase complex by protein Z-dependent protease inhibitor. Heeb MJ; Cabral KM; Ruan L J Biol Chem; 2005 Oct; 280(40):33819-25. PubMed ID: 16093243 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms for the anticoagulant effect of heparin and related polysaccharides. Ofosu FA Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155 [TBL] [Abstract][Full Text] [Related]
16. The influence of sodium ion binding on factor IXa activity. Gopalakrishna K; Rezaie AR Thromb Haemost; 2006 Jun; 95(6):936-41. PubMed ID: 16732371 [TBL] [Abstract][Full Text] [Related]
17. Factor IX a inhibition contributes to the heparin effect. Béguin S; Dol F; Hemker HC Thromb Haemost; 1991 Sep; 66(3):306-9. PubMed ID: 1746001 [TBL] [Abstract][Full Text] [Related]
18. Maturation of coagulation factor IX during Xase formation as deduced using factor VIII-derived peptides. Fang H; Zögg T; Brandstetter H FEBS Open Bio; 2019 Aug; 9(8):1370-1378. PubMed ID: 31077577 [TBL] [Abstract][Full Text] [Related]
19. Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque. Ananyeva NM; Kouiavskaia DV; Shima M; Saenko EL Blood; 2002 Jun; 99(12):4475-85. PubMed ID: 12036878 [TBL] [Abstract][Full Text] [Related]
20. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin. Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]